Study Design: This experimental study was performed using human ligamentum flavum–derived cells (HFCs).Purpose: To investigate the intracellular signaling mechanism of interleukin-6 (IL-6) secretion in transforming growth factor-β (TGF- β)-stimulated HFCs.Overview of Literature: Lumbar spinal stenosis (LSS) is a prevalent disease among the elderly, characterized by debilitating pain in the lower extremities. Although the number of patients with LSS has increased in recent years, the underlying pathomechanism remains unclear. Clinical examinations typically rely on magnetic resonance imaging to diagnose patients, revealing ligamentum flavum hypertrophy. Some studies have suggested an association between ligamentum flavum hypertrophy and inflammation/fibrosis, and expression of TGF-β and IL-6 has been observed in surgically obtained ligamentum flavum samples. However, direct evidence linking TGF-β and IL-6 expression in HFCs is lacking.Methods: HFCs were obtained from patients with LSS who had undergone decompression surgery. The cells were stimulated with TGF-β and pretreated with either the p38 mitogen-activated protein (MAP) kinase inhibitor SB203580 or the p44/42 MAP kinase inhibitor FR180204. IL-6 secretion in the cell culture medium and IL-6 messenger RNA (mRNA) expression levels were analyzed using an enzyme-linked immunoassay and real-time polymerase chain reaction, respectively.Results: TGF-β administration resulted in a dose- and time-dependent stimulation of IL-6 release. Treatment with SB203580 and FR180204 markedly suppressed TGF-β–induced IL-6 secretion from HFCs. Moreover, these inhibitors suppressed IL-6 mRNA expression in response to TGF-β stimulation.Conclusions: Our findings indicate that TGF-β induces IL-6 protein secretion and gene expression in HFCs through the activation of p38 or p44/42 MAP kinases. These results suggest a potential association between IL-6–mediated inflammatory response and tissue hypertrophy in LSS, and we provide insights into molecular targets for therapeutic interventions targeting LSS-related inflammation through our analysis of the MAP kinase pathway using HFCs.
Case: A 19-year-old man sustained a right palm laceration from a broken glass bottle, presenting with finger numbness. Tinel sign was positive over the carpal tunnel, and thumb opposition was impaired. Surgical exploration revealed a median nerve injury with Wallerian degeneration. After debridement, a 10-mm segmental defect was observed on the ulnar side. The nerve was repaired using the Renerve® synthetic collagen conduit. At 31 months postoperatively, the patient showed significant functional recovery, including restored thumb opposition and improved sensation, although sensory misdirection was observed. Conclusion: Collagen nerve conduits may be effective for motor nerve injuries when conditions favor regeneration.
Case: A 5‐year‐old boy presented with right‐hand pain and was diagnosed with a bone tumor in his fifth metacarpal. Because the patient wished to resume sports activities, endoscopic curettage (ESC) was performed. The pathological diagnosis of the tumor was aneurysmal bone cyst (ABC). As recurrence was observed 1 year after the first ESC, a second ESC was performed. Postoperatively, the bone healed without complications, allowing the patient to resume physical activity. Conclusion: ESC can be performed in a tiny metacarpal of a child. The endoscopic treatment may be a feasible treatment option for ABCs in the hand.